赵婷婷，博士，中日友好医院临床医学研究所副研究员，协和医科大学、北京医科大学和首都医科大学硕士生导师。曾于2012-2013 年赴香港中文大学李嘉诚健康研究所访问，于2017.09-12赴美国耶鲁大学肾脏病系访问。

先后主持科技部重大新药创制课题 1 项、国家自然科学基金项目 4项，北京市自然科学基金面上项目 2 项、人社部留学回国人员科技活动项目 1 项等。作为副主编出版专著《糖尿病肾病中西医结合诊疗与研究》，参编专著 1 部，发表学术论文 50 余篇，其中 SCI 论文25 篇，先后获得国家科技进步二等奖 1 项，省部级以上学术奖励奖 4 项，兼任Integrative Medicine in Nephrology and Andrology编委，国家自然科学基金同行评议专家、中国中西医结合学会肾脏病专业委员会青年委员，中华中医药学会中药实验药理分会青年委员、世界中联肾病专业委员会第三届理事会理事等社会职务。

研究方向

1. 中药治疗慢性肾脏病机制研究和新药研发

2. 糖尿病肾病临床标志物研究

3. 医用增塑剂安全性评价研究

合作或招生需求:

1.常年招收基础医学、病理生理学、中西医结合基础、药理学等相关专业联合培养研究生。

2.研究生需对科研有较强的兴趣、勤奋努力、良好的沟通能力。

联系方式:ttfrfr@163.com

出版专著 

1、《糖尿病肾病中西医结合诊疗与研究》李平、谢院生主编，赵婷婷副主编， 中国医药科技出版社，2018

代表性学术论文

1、 Wan Y, Wang S, Chen K, Liu L, Wang X, Zhang B, Hu L, Liu S, Zhao T*. (赵婷婷，共同通讯), Qi H*. High-sulfated derivative of polysaccharide from Ulva pertusa improves Adriamycin-induced nephrotic syndrome by suppressing oxidative stress. Food Funct. 2023 Sep 18. doi: 10.1039/d3fo01290e.

2、 Wang S, Zhang B, Chang X, Zhao H, Zhang H, Zhao T*. (赵婷婷，共同通讯), Qi H*. Potential use of seaweed polysaccharides as prebiotics for management of metabolic syndrome: a review. Crit Rev Food Sci Nutr. 2023 Mar 27:1-21.

3、 Wan Y, Liu L, Zhang B, Wang S, Wang X, Chen K, Li Y, Zhao T*. (赵婷婷，共同通讯), Qi H*. Structural Characterization and Anti-Nonalcoholic Fatty Liver Effect of High-Sulfated Ulva pertusa Polysaccharide. Pharmaceuticals (Basel). 2022 Dec 31;16(1):62.

4、 Zhang B, Wan Y, Zhou X, Zhang H, Zhao H, Ma L, Dong X, Yan M, Zhao T*. (赵婷婷，共同通讯) and Li P* (2022) Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease. Front. Pharmacol. 13:872988.

5、 Hu L, Wang Y, Wan Y, Ma L, Zhao T*. (赵婷婷，共同通讯), Li P*. Tangshen Formula Improves Diabetes-Associated Myocardial Fibrosis by Inhibiting TGF-β/Smads and Wnt/β-Catenin Pathways. Front Med (Lausanne). 2021;8:732042.

6、 Zhao T T（赵婷婷）, Zhang H J, Yin XB, Zhao HL, Yan MH, Peng L, Wang Q, Dong X, Li P. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomedicine &Pharmacotherapy 2020, 129, 110325.

7、 Li X, Li X, Zhang Q*, Zhao T*. (赵婷婷，共同通讯). Low molecular weight fucoidan and its fractions inhibit renalepithelial mesenchymal transition induced by TGF-1 or FGF-2. International Journal of Biological Macromolecules. 2017, Pt2(105): 1482-1490.

8、 Wang Q, Tian X, Zhou W, Wang Y, Zhao H, Li J, Zhou X, Zhang H, Zhao T*. (赵婷婷，共同通讯 ), &Li P*. (2020). Protective Role of Tangshen Formula on the Progression of Renal Damage in db/db Mice by TRPC6/Talin1 Pathway in Podocytes. Journal of diabetes research, 2020, 3634974.17

9、 Wang Q, Tian X, Wang Y, Zhao T(赵婷婷，共同通讯)*, Ping Li*. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement. Journal of Diabetes Research. 2020,2020:6897390.

10、 Han J, Wang X, Hou J, Liu Y, Liu P, Zhao T*( 赵婷婷 ). Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic Nephropathy. Biomed Res Int. 2021 Feb 1;2021:6642584.

11、 Liu Y, Chen DQ, Han JX, Zhao TT*(赵婷婷，共同通讯), Li SJ*. A Review of Traditional Chinese Medicine in Treating Renal Interstitial Fibrosis via Endoplasmic Reticulum Stress-Mediated Apoptosis. Biomed Res Int. 2021 May 15;2021:6667791.

12、 Yao Y, Yu YC, Cai MR, Zhang ZQ, Bai J, Wu HM, Li P, Zhao TT*(赵婷婷，共同通讯), Ni J*, Yin XB*. UPLC-MS/MS method for the determination of the herb composition of Tangshen formula and the in vivo pharmacokinetics of its metabolites in rat plasma. Phytochem Anal.  2022, 33(3):402-426.